Trial Profile
A Randomized, Evaluator-Blinded, Phase 2 Study to Compare the Safety and Efficacy of PTK 0796 With Linezolid (Zyvox®) in the Treatment of Adults With Complicated Skin and Skin Structure Infection (cSSSI)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 Apr 2023
Price :
$35
*
At a glance
- Drugs Omadacycline (Primary) ; Omadacycline (Primary) ; Linezolid; Linezolid
- Indications Skin and soft tissue infections; Staphylococcal infections
- Focus Therapeutic Use
- Sponsors Paratek Pharmaceuticals
- 05 Jun 2017 Results of pooled post-hoc analysis presented at the ASM Microbe 2017
- 12 Apr 2016 Results of a pooled analysis (n=377) from this and other phase III trial (see profile 32711) presented at the 26th European Congress of Clinical Microbiology and Infectious Diseases
- 11 Apr 2016 Results of pooled analysis (n=377) from this and other phase III trial (see profile 32711) published in the Paratek Pharmaceuticals media release.